Is a complete BOLT research report available?

No complete published report is available for Bolt Biotherapeutics, Inc. (BOLT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · USD

$3.83

+0.02 (+0.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BOLT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	7.4M
Revenue (ttm)	6.5M
Net income (ttm)	-29.6M
EPS (ttm)	-$16.3
Shares out	1.9M
Volume	4,176.309
Beta	1.16
Price target	$41.0	+970.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.5M
Net income (ttm): -29.6M
EPS (ttm): -$16.3
Market cap: 7.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BOLT indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001641281
Company name	Bolt Biotherapeutics, Inc.
Country	United States
Country code	US
Cusip	097702203
Employees	23
Employees Change	-29%
Employees Change Percent	-55.77
Enterprise value	$7.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-05
Isin	US0977022039
Last refreshed	2026-07-25
Market cap	$7.4M
Market cap category	Nano-Cap
Price	$3.83
Price currency	USD
Rev Per Employee	282,565.22x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	BOLT
Website	https://www.boltbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-380.15%
EV Sales Forward	4.8x
EV/Sales	1.11x
FCF yield	-444.4%
P/B ratio	0.37x
P/S ratio	1.2x
PS Forward	5.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-486.21%
EBITDA Margin	-469.36%
Gross margin	-268.15%
Gross Profit	$-17.4M
Net Income	$-29.6M
Net Income Growth Quarters	4%
Net Income Growth Years	4%
Pretax Margin	-455.15%
Profit Per Employee	$-1.3M
ROA	-28.12
Roa5y	-27.79
ROCE	-77.67
ROE	-88.79
Roe5y	-63.21
ROIC	-33.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-42.94%
Cagr3y	-48.22%
Cagr5y	-56.54%
EPS Growth Quarters	4
EPS Growth Years	5
Revenue Growth	78.64x
Revenue Growth Q	-97.87x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.22x
Revenue Growth5 Y	149.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.1
Assets	$48M
Cash	$22.9M
Current Assets	$25.8M
Current Liabilities	$7.3M
Debt	$22.3M
Debt Equity	$1.13
Equity	$19.8M
Liabilities	$28.2M
Long Term Assets	$22.3M
Long Term Liabilities	$20.9M
Net Cash	$584,000
Net Cash By Market Cap	$7.51
Net Cash Growth	-95.87%
Net Debt Equity	$-0.03
Tangible Book Value	$19.8M
Tangible Book Value Per Share	$10.32
WACC	2.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.51
Net Working Capital	$-1.5M
Quick ratio	3.12
Working Capital	$18.4M
Working Capital Turnover	$0.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.32%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-42.92%
200-day SMA	5
3Y total return	-86.12%
50-day SMA	4.42
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.45%
All Time High	861.4
All Time High Change	-99.56%
All Time High Date	2021-03-11
All Time Low	3.75
All Time Low Change	2.13%
All Time Low Date	2026-06-22
ATR	0.3
Beta	1.16
Beta1y	0.6
Beta2y	0.35
Ch YTD	-29.96
High	4.1
High52	7.2
High52 Date	2026-01-16
High52ch	-46.81%
Low	3.83
Low52	3.75
Low52 Date	2026-06-22
Low52ch	2.13%
Ma50ch	-13.31%
Price vs 200-day SMA	-23.38%
RSI	41.25
RSI Monthly	27.3
RSI Weekly	39.95
Sharpe ratio	-0.47x
Sortino ratio	-0.62
Total Return	5.32%
Tr YTD	-29.96
Tr1m	-10.2%
Tr1w	-13.35%
Tr3m	-19.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$7
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-17.44
Earnings Revenue Estimate	700,000x
Earnings Revenue Estimate Growth	-61.2x
Operating Income	$-30.1M
Operating margin	-463.4
Price target	$41
Price Target Change	$970
Price Target Change Top	$82.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,771,395%
Float Percent	92.18%
Shares Insiders	0.65%
Shares Institutions	24.75%
Shares Out	1,921,567
Shares Qo Q	-2.71%
Shares Yo Y	-5.32%
Short Float	0.94%
Short Ratio	0.52
Short Shares	0.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-37.2M
Average Volume	19,363.5x
Bv Per Share	10.32
CAPEX	$-72,000
Ch1m	-10.2
Ch1w	-13.35
Ch1y	-42.92
Ch3m	-19.71
Ch3y	-86.12
Ch5y	-98.45
Ch6m	-42.66
Change	0.52%
Change From Open	-3.04
Close	3.81
Days Gap	3.67
Depreciation Amortization	1,095,000
Dollar Volume	15,995.3
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-31.6M
EBITDA	$-30.5M
EPS	$-16.34
F Score	3
FCF	$-34.6M
FCF EV Yield	-480.47x
FCF Per Share	$-18
Financing CF	25,000
Fiscal Year End	December
Founded	2,015
Investing CF	37,674,000
Ipr	-79.75
Iprfo	-99.22
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2025-06-09
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	4.87
Ma150ch	-21.39%
Ma20	4.04
Ma20ch	-5.2%
Net CF	3,191,000
Next Earnings Date	2026-08-13
Open	3.95
Optionable	No
Position In Range	0
Ppne	19,606,000
Price Date	2026-07-24
Ptbv Ratio	0.39
Relative Volume	0.22x
Revenue	6,499,000x
SBC By Revenue	40.28x
Share Based Comp	2,618,000
Tr6m	-42.66%
Us State	California
Volume	4,176.3
Z Score	-14.89

Bolt Biotherapeutics, Inc. (BOLT)

Coverage state: Market snapshot only — no published research

Generate the first BOLT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BOLT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOLT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BOLT

Frequently asked questions